glutathione formaldehyde dehydrogenase - an overview Glutathione Depletion and Stalwart Anticancer
Description
This pattern was confirmed by independent datasets 30,31 (Supplementary Fig
Together, these reports indicating that cells resistant to antimony-(III) are not resistant to stibogluconate [antimony-(V)] lead us to the hypothesis that gluconate could be an, if not the, active anti-cancer substance in this scenario
Clinical trial subgroup analyses consistently show that participants with a BMI of 35 or higher lose a larger percentage of body weight than those with lower BMIs
Although the use of these systems might control the spread of microbial pathogens, the effects observed in this study are not optimal
